Healthcare Tech Firm Grows Revenue 10% YOY in Q1/23 June 6, 2023 (Investorideas.com Newswire) This positive start to 2023 bodes well for the company turning EBITDA positive later this year

FDA Approval, Private Placement Funding Buoy Biotech Firm June 6, 2023 (Investorideas.com Newswire) Krystal Biotech Inc. appears to be picking up steam for the year's second half.

Biotech Stock News: Defence (CSE: DTC) Begins Testing Its Arm Vaccine Against Pancreatic Cancer Vancouver, British Columbia - June 6, 2023 (Newsfile Corp.) (Investorideas.com Newswire) Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce that it mandated Transbiotech Biotechnology Research and Transfer Center to initiate testing its cellular anti-cancer ARM vaccine against deadly pancreatic cancer.

Telehealth Co. Notches First Profitable Quarter June 5, 2023 (Investorideas.com Newswire) Reliq Health Technologies announces record revenues for the three months ending March 31 and its first profitable quarter after a loss during the same quarter in 2022.

Ecuador's President Signs Decree for Bioleaching Plant Permit June 2, 2023 (Investorideas.com Newswire) Ecuador's president signs a decree clearing the way for green technology company BacTech Environmental Corp. to construct its bioleaching plant in the South American country.

Analyst Says Pharma Co. 'Meaningfully Undervalued' June 2, 2023 (Investorideas.com Newswire) "We continue to view Mindset as meaningfully undervalued," Stefan Quennevill reported in an Echelon Capital Markets research note.

Stock of Canadian Health Tech Firm Upgraded To Good June 2, 2023 (Investorideas.com Newswire) Since the previous rating, this firm has experienced improvements in its business market sentiment and technicals

Telehealth Co. Signs Contract With US Health Plan Serving 1 Million Patients May 19, 2023 (Investorideas.com Newswire) Telehealth company Reliq Health Technologies signs a contract with a U.S. health plan that operates in five states with over 3,000 doctors and more than 1 million patients.

Biopharma Co. Ceases Program to Optimize Resources May 17, 2023 (Investorideas.com Newswire) This French developer of investigative cancer therapies is focused on advanced its remaining programs and is amply funded to do so

Telehealth Co. Expands into Arkansas May 8, 2023 (Investorideas.com Newswire) Telehealth company Reliq Health Technologies signs five new contracts in four states for its iUGO platform

Subscribe to Biotech News RSS

Submit Articles   Search More Articles

First Trust NYSE Arca Biotech ETF ( NYSEArca: FBT ) The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.

iShares US Healthcare ( NYSEArca: IYH ) The investment seeks to track the investment results of an index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Health Care Index (the "underlying index"), which measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.

iShares US Healthcare Providers ( NYSEArca: IHF ) The investment seeks to track the investment results of an index composed of U.S. equities in the healthcare providers sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Health Care Providers Index (the "underlying index"), which measures the performance of the healthcare providers sector of the U.S. equity market. The fund is non-diversified.

iShares US Medical Devices ( NYSEArca: IHI ) The investment seeks to track the investment results of an index composed of U.S. equities in the medical devices sector. The fund seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index (the "underlying index"), which measures the performance of the medical equipment sector of the U.S. equity market. The underlying index includes medical equipment companies such as manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.

iShares Nasdaq Biotechnology ( NasdaqGIDS IBB ) The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.

Market Vectors Biotech ETF ( NYSE MKT:BBH ) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

PowerShares Dynamic Biotech & Genome ETF ( NYSEArca: PBE ) The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

How to Prove Wrongful Death - February 1, 2022

Healthcare Supply Chain Management Software - November 29, 2021

Overview of Biotech Stocks - What Could Happen by the End of 2021? - November 3, 2021

Consider Investing In These Disruptive Medical Companies In 2021 - April 16, 2021

Resources for Physicians and Medical Practices - December 31, 2020

Lockdown Part 2: The South African Economy and the Rand - December 15, 2020

How to Get Into Canada during COVID - November 30, 2020

The Impact of Gynecomastia on Your Mental Health and How to Deal With the Condition - September 8, 2020

Does Income Protection Cover Me for a COVID Redundancy? - August 10, 2020

Everything You Need to Know About Investing in Healthcare Stocks - March 30, 2020

The Rise Of The At-Home Testing Market - January 16, 2020

Why Do You Need Birth Injury Lawyer and How They Can Help You? - October 2, 2019

5 Key Tips For Renting a Boardroom - August 14, 2018

How to Go About Choosing a Medical Malpractice Lawyer - February 13, 2018

Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option Encinitas, California--(Newsfile Corp. - June 6, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the closing of an underwritten public offering for gross proceeds of approximately $6.3 million, which includes full exercise of the underwriter's over-allotment option to purchase additional shares and warrants, prior to deducting underwriting discounts and commissions and offering expenses.The offering was comprised of (i) 1,447,628 shares of common...

Telo Genomics Announces Private Placement Increased to $2,766,375 from Previously Announced Private Placement of $2,000,000 Toronto, Ontario--(Newsfile Corp. - June 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is pleased to announce that it has increased the size of its previously announced non-brokered private placement ("Offering") from up to $2 million in proceeds to $2,766,375 and 11,065,500 units (the "Units" or each a "Unit").Each Unit will consist of one common share of the Company (a "Common Share") and one-half of one non-transferable common share purchase warrant...

Britannia Life Sciences Announces Strategic Investment in Cosmetics Lab Ltd. Cosmetics Lab is a U.K.-based service provider to the cosmetics industry offering a full range of new product development support and advanced manufacturing servicesBroadens Britannia's already robust service offering for new and existing clients by further vertically integrating its expertise across the value chainAdds significant operational expertise in formulation, manufacturing, ingredient sourcing, and supply chain management, providing a one-stop-shop for clients in the cosmetic and...

BioHarvest Sciences Adds Renowned Scientist to Scientific Advisory Board Vancouver, British Columbia  and Rehovot, Israel--(Newsfile Corp. - June 6, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) announces that it has added Dr. John Paul SanGiovanni, world renowned nutritionist and Harvard-trained scientist, to its Medical and Scientific Advisory board. Dr. SanGiovanni will act as a liaison with the spheres of Academia, Industry, and Government, helping spread the promise and potential of Botanical Synthesis. His deep connections within Academic and research...

Zonetail Is Pleased to Announce It Has Signed an Agreement with One of the Largest Property Management Companies in Canada, Representing over 50,000 Apartment Units Toronto, Ontario--(Newsfile Corp. - June 6, 2023) - Zonetail Inc. (TSXV: ZONE) (OTCQB:ZTLLF) ("Zonetail" or the "Company") is pleased to announce that it has signed an agreement with one of the largest property management companies ("PMC") in Canada representing over 50,000 apartments. The launch is planned to begin in Ontario, and rollout across the country over the coming weeks.Zonetail's latest PMC client, currently utilizes a mobile application as their tenant portal, allowing residents to...

Subscribe to Biotech News